Jacobi Capital Management’s Sophiris Bio, Inc. SPHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-400
Closed 1246
2019
Q4
$0 Hold
400
﹤0.01% 1136
2019
Q3
$0 Hold
400
﹤0.01% 1110
2019
Q2
$0 Hold
400
﹤0.01% 1092
2019
Q1
$0 Hold
400
﹤0.01% 1060
2018
Q4
$0 Hold
400
﹤0.01% 1053
2018
Q3
$1K Hold
400
﹤0.01% 970
2018
Q2
$1K Hold
400
﹤0.01% 1003
2018
Q1
$1K Hold
400
﹤0.01% 973
2017
Q4
$1K Hold
400
﹤0.01% 913
2017
Q3
$1K Hold
400
﹤0.01% 898
2017
Q2
$1K Hold
400
﹤0.01% 820
2017
Q1
$1K Hold
400
﹤0.01% 688
2016
Q4
$1K Hold
400
﹤0.01% 602
2016
Q3
$1K Buy
+400
New +$1.5K ﹤0.01% 708

Other funds holding SPHS

Jacobi Capital Management's SPHS Position: Q1 2020 in Review

Jacobi Capital Management sold out of Sophiris Bio, Inc. (SPHS) in Q1 2020, closing a stake of 400 shares.

Jacobi Capital Management first reported a position in SPHS in Q3 2016 and held it in 14 quarters. The position peaked at $1K in Q3 2018. 3 funds tracked by Wall St. Rank hold SPHS as of Q1 2020.

  • Jacobi Capital Management reported no remaining Sophiris Bio, Inc. position as of Q1 2020 after selling out during the quarter.
  • Jacobi Capital Management sold 400 Sophiris Bio, Inc. shares in Q1 2020.
  • Jacobi Capital Management first reported a position in Sophiris Bio, Inc. in Q3 2016 and held it in 14 quarters.
  • Jacobi Capital Management's Sophiris Bio, Inc. position peaked at $1K in Q3 2018.
  • 3 funds tracked by Wall St. Rank held Sophiris Bio, Inc. as of Q1 2020.

Based on Jacobi Capital Management's 13F filing for Q1 2020, filed 24 Apr 2020.